RUA — Rua Bioscience Share News
0.000.00%
Last trade - 00:00- NZ$11.77m
- NZ$12.99m
- NZ$2.58m
Brief: Rua Bioscience Ltd Sees Revenue Over NZ$3Mln By End Of FY25
Brief: Rua Bioscience Announces Rights Offer To Raise Up To NZ$3.1 Mln
Brief: Rua Bioscience Says Not Received Settlement Funds For Sale Of Gisborne Manufacturing Facility
Brief: Rua Bioscience Expect Revenue From Customers In Fy25 Will Be Significantly Higher
Brief: Rua Bioscience Posts FY Revenue NZD 320 Thousand
Brief: Rua Bioscience Announces Sales Of Gisborne Manufacturing Facility
Brief: Rua Bioscience Partners With Alphafarma For Supply To Germany
Brief: Rua Bioscience Signs Agreement With Cannprisma
Brief: Rua Bioscience Posts HY Net Loss Before Tax Of NZ$10.9 Million
Brief: Cann Group Says To Defend Legal Proceedings Brought By Rua Biosciences
Brief: Rua Bioscience Commences Legal Proceedings Against Cann Group
NZ's Rua Bioscience scales 2-month high on agreement with Apollo Green
Brief: Rua Bioscience Expands International Reach To Canada
Brief: Rua Bioscience Expands Global Reach With UK Distribution Agreement
Brief: Rua Bioscience Says There Have Been Recent Quality Issues With Cann's Export Products
Brief: Rua Bioscience Says Supply Line Strengthens With Schroll Medical Agreement
Brief: Rua Bioscience Posts Loss Before Tax For FY23 NZ$6 Million
Brief: Rua Bioscience Getts Australian Licences For Wholesale, Trade Activities Of Medicinal Cannabis
Brief: Rua Bioscience Says Introduced A Branded Product In Germany